NDC 70954-668 – Pentoxifylline
Pentoxifylline 400 mg/1 · Tablet, Extended Release · Oral
Product NDC70954-668
Product details
- Brand name
- Pentoxifylline
- Generic name
- Pentoxifylline
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA074878
- Marketed since
- January 15, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Blood Viscosity Reducer
Active ingredients
- Pentoxifylline 400 mg/1
Uses, dosage, side effects and warnings for Pentoxifylline →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 70954-668-10 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70954-668-10) | Jan 15, 2024 |
| 70954-668-20 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70954-668-20) | Jan 15, 2024 |
Other Pentoxifylline products
- 60505-0033 Pentoxifylline 400 mg/1 · Tablet, Extended Release · Apotex Corp.
- 63629-2910 Pentoxifylline 400 mg/1 · Tablet, Extended Release · Bryant Ranch Prepack
- 71335-2586 Pentoxifylline 400 mg/1 · Tablet, Extended Release · Bryant Ranch Prepack
- 0904-5448 Pentoxifylline 400 mg/1 · Tablet, Extended Release · Major Pharmaceuticals
- 0615-8511 Pentoxifylline 400 mg/1 · Tablet, Extended Release · NCS HealthCare of KY, LLC dba Vangard Labs
- 16571-856 Pentoxifylline 400 mg/1 · Tablet, Extended Release · Rising Pharma Holdings, Inc.